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Abstract
Background: The interactive effect of cumulative input and output on achieving optimal fluid balance has not
been well elucidated in patients with acute kidney injury (AKI) requiring continuous renal replacement therapy
(CRRT). This study evaluated the interrelation of fluid components with mortality in patients with AKI requiring CRRT.
Methods: This is a retrospective observational study conducted with a total of 258 patients who were treated with
CRRT due to AKI between 2016 and 2018 in the intensive care unit of Ewha Womans University Mokdong Hospital. The
amounts of fluid input and output were assessed at 24-h and 72-h from the initiation of CRRT. The study endpoints
were 7- and 28-day all-cause mortality.
Results: The mean patient age was 64.7 ± 15.8 years, and 165 (64.0%) patients were male. During the follow-up, 7- and
28-day mortalities were observed in 120 (46.5%) and 157 (60.9%) cases. The patients were stratified into two groups
(28-day survivors vs. non-survivors), and the cumulative fluid balances (CFBs) at 24 h and 72 h were significantly higher
in the 28-day non-survivors compared with the survivors. The increase in 24-h and 72-h CFB was significantly associated
with an increase in 7- and 28-day mortality risks. To examine the interactive effect of cumulative input or output on the
impact of CFB on mortality, we also stratified patients into three groups based on the tertile of 24-h and 72-h cumulative
input or output. The increases in 24-h and 72-h CFBs were still significantly related to the increases in 7-day and 28-day
mortality, irrespective of the cumulative input. However, we did not find significant associations between increase in 24-h
and 72-h CFB and increase in mortality risk in the groups according to cumulative output tertile.
Conclusions: The impact of cumulative fluid balance on mortality might be more dependent on cumulative output. The
physicians need to decrease the cumulative fluid balance of CRRT patients as much as possible and consider increasing
patient removal.
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Background
Fluid overload has been associated with aggravating
renal dysfunction, an increase in length of intensive care
unit (ICU) stay, and an elevation in mortality risk [1–4].
Hence, negative fluid balance is regarded as an essential
strategy to improve survival rates in critically ill patients,
and continuous renal replacement therapy (CRRT) has
been widely used for fluid regulation in critically ill pa-
tients with acute kidney injury (AKI) [5–7]. However,
there is no consensus on the optimal fluid management
for such patients [8–12]. Several recent studies revealed
that an increase of cumulative fluid balance (CFB) was
significantly associated with an increase in mortality risk
in critically ill patients [13–17], while Balakumar et al.
showed that both positive and negative fluid balance
were associated with higher mortality rates compared
with even fluid balance [18]. Furthermore, Silversides
et al. reported that active removal of fluid using RRT in
critically ill patients was associated with less survival
benefit compared with standard care [19–21].
Fluid resuscitation for critically ill patients with AKI
has both advantages and disadvantages. Fluid resuscita-
tion can help keep patients hemodynamically stable,
maintain renal perfusion, and prevent further ischemic
injury due to ongoing renal dysfunction. However, accu-
mulating interstitial fluid hinders oxygen delivery to cells
from blood vessels and can lead to renal ischemia and
multi-organ failure [9, 12, 22]. Thus, optimal manage-
ment of fluid balance in patients with AKI, especially
those requiring CRRT, still needs to be investigated. In
addition, most physicians have focused on CFB, even
though CFB is determined by the amount of input and
output. However, there is still no definite answer for
which strategies better benefit survival: does higher out-
put translate into better clinical outcomes, or does lower
input translate into better clinical outcomes. Therefore,
in this study, we investigated the association between
CFB, cumulative input and output amounts at 24-h and
72-h after initiation of CRRT, and mortality risk among
patients with AKI receiving CRRT.
Methods
Study population
We conducted a retrospective review of patients aged
18 years or older who were treated with CRRT due to
AKI between 2016 and 2018 in the ICU of Ewha
Womans University Mokdong Hospital. A total 330 pa-
tients were initially screened. Exclusion criteria included
patients with end-stage renal disease (ESRD) on chronic
dialysis or those who underwent kidney transplantation,
patients who died within 24-h immediately after CRRT
initiation, and patients with missing fluid status data.
Finally, a total of 258 patients with 24-h assessment of
fluid status and 191 patients with 72-h assessment of
fluid status were analyzed (Additional file 1: Figure S1).
All the enrolled patients received CRRT management
for longer than 24-h. This study was approved by the In-
stitutional Review Board of Ewha Womans University,
College of Medicine (IRB No. EUMC 2018-11-019). The
need for informed consent from patients was waived be-
cause of the retrospective study design. All clinical inves-
tigations were conducted in accordance with 2013
Declaration of Helsinki guidelines.
Data collection
Baseline characteristics of the enrolled patients were
collected at the time of CRRT initiation, including age,
sex, body mass index (BMI), cause of AKI, systolic blood
pressure (SBP), diastolic blood pressure (DBP), mean
arterial pressure (MAP), comorbidities (hypertension,
diabetes mellitus, cardiovascular disease, malignancy),
Charlson Comorbidity Index (CCI), Sequential Organ
Failure Assessment (SOFA) score, Acute Physiology and
Chronic Health Evaluation (APACHE) II score, and
Glasgow Coma Score (GCS). In addition, the needs for
mechanical ventilation and fraction of inspired oxygen
(FiO2) were investigated, and the prescriptions for
CRRT including target clearance, dialysate flow rate, re-
placement flow rate, and use of anticoagulation were
also assessed. Laboratory data were collected at the initi-
ation of CRRT, and estimated glomerular filtration rate
(eGFR) was calculated using the Modification of Diet in
Renal Disease equation [23]. The definition of AKI, based
on the Kidney Disease: Improving Global Outcomes clin-
ical practice guidelines for AKI, was the presence of at
least one of the following criteria: (1) an increase in serum
creatinine level ≥ 0.3mg/dL within 48-h, (2) an increase in
serum creatinine level to ≥ 1.5 times the baseline level that
was known or presumed to have occurred within the pre-
vious 7 days, or (3) urine volume < 0.5mL/kg/h for 6-h
[24].
CRRT protocol
The decision to initiate CRRT and the CRRT settings for
target clearance; blood flow, dialysate, and replacement
fluid rates; and anticoagulation administration were
determined through discussion and consultation with
nephrologists [25]. The criteria for CRRT initiation were
medically intractable or persistent electrolyte imbalance
and/or metabolic acidosis and decreased urine output
with volume overload and/or progressive azotemia.
Hemodynamic instability was also an important indica-
tion. Generally, vascular access for CRRT was via a fem-
oral venous catheter, and the pre-dilution method of
continuous venovenous hemodiafiltration was usually
performed. After CRRT initiation, attending physicians
and experienced nurses monitored body weight, urine
output, laboratory results, actual delivered dose, and the
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hemodynamic status of the patients and discussed the
results with nephrologists to maintain CRRT adequacy.
Fluid status assessment
The amounts of cumulative fluid input and output were
assessed for 24-h and 72-h from the initiation of CRRT,
and the CFB was calculated as cumulative input − cumu-
lative output. We also investigated the type of infused
fluid, including 0.9% sodium chloride, 0.45% sodium
chloride, dextrose, plasma solution, lactate Ringer’s solu-
tion, 20% albumin, and enteral nutritional fluid, and
compared the administered type between the 28-day
survivors and non-survivors.
Statistical analysis
Patients were stratified into two groups: 28-day survivors
vs. non-survivors. The baseline characteristics of the
groups were compared using the independent t-test for
continuous variables and the chi-squared test for cat-
egorical variables. Continuous variables are presented as
the mean ± standard deviation, and categorical variables
are presented as numbers and percentages. The non-
normally distributed variables were expressed as me-
dians (25th–75th percentiles) and were compared using
the Mann-Whitney U or Kruskal-Wallis test. The study
endpoints were all-cause mortality on the 7- and 28-day
time points after commencing CRRT, and Cox propor-
tional hazard analyses were performed to examine the
effects of CFB on mortality. Significant covariates were
identified by univariable analysis (P < 0.05), and the clin-
ically important variables were selected for multivariable
analysis. Age, sex, BMI, CCI, medical history, and eGFR
at CRRT initiation were adjusted for multivariable Cox
proportional regression analyses, as were the MAP,
hemoglobin, SOFA score, use of vasopressor, and type of
fluid administration at each time point (24-h and 72-h
from CRRT start). Before investigating the interactive ef-
fect of cumulative input or output on the impact of CFB
on mortality, multicollinearity between CFB and cumu-
lative input or output was assessed based on the variance
inflation factor (VIF). However, we found that the VIF
was too large to adjust the cumulative input or output
to show the effect of CFB on mortality risk, so we de-
cided to analyze the effect of cumulative input and out-
put on the impact of CFB on mortality after stratifying
the patients. Thus, we stratified patients into three
groups based on the tertile of 24-h and 72-h cumulative
input or output and investigated the impact of CFB on
the mortality in each group. All statistical tests were
conducted using a two-tailed 95% confidence interval
(CI), and a P value of less than 0.05 was considered sta-
tistically significant. All descriptive and survival analyses
were performed using SPSS for Windows, version 23.0
(IBM, Armonk, NY, USA) and R software version 3.3.1
(R Development Core Team, Vienna, Austria).
Results
Baseline characteristics and clinical parameters at the
time of CRRT initiation
The baseline characteristics and clinical and laboratory
parameters at baseline are shown in Tables 1 and 2. The
mean patient age was 64.7 ± 15.8 years, and 165 patients
(64.0%) were male. The primary cause of AKI was sepsis
(n = 157, 60.9%) followed by ischemic injuries (n = 52,
20.2%). Among the total 258 patients, 157 patients (61%)
died within 28 days after CRRT initiation. The patients
were stratified into two groups, the 28-day survivors and
the non-survivors. The SOFA, APACHE II score, and
the need for mechanical ventilation were significantly
higher in the 28-day non-survivors than in the survivors.
Moreover, there was significantly more malignancy in
the non-survivors compared with the survivors, while
the survivors had significantly more hypertension com-
pared with non-survivors (Table 1). Furthermore, the
mean SBP and MAP were significantly higher in the sur-
vivors compared with the non-survivors. The mean
platelet counts were significantly increased in the survi-
vors compared with the non-survivors, whereas the
mean total bilirubin level was significantly decreased in
the survivors. There were no significant differences in
the type of fluid administration or replacement of 20%
albumin between the two groups, but the survivors re-
ceived more enteral nutritional fluid than the non-
survivors. The prescriptions for CRRT did not differ
between two groups except for CRRT duration, which
was longer in the survivors (Table 2). We further com-
pared clinical parameters between the two groups at 24-
h and 72-h after CRRT initiation, respectively (Add-
itional file 1: Table S1 and S2). The SOFA and APA-
CHE II scores, and need for mechanical ventilation
were significantly higher in the non-survivors than
the survivors at both 24-h and 72-h assessment after
CRRT initiation. Furthermore, the mean MAP and
platelet counts were lower, whereas white blood cell
counts and total bilirubin levels were higher in the
non-survivors compared to the survivors at both 24-h
and 72-h assessment after CRRT initiation.
Change of CFB and cumulative input and output in
survivors and non-survivors
We assessed the CFB and total cumulative input and
output at 24-h and 72-h after initiation of CRRT, and
Fig. 1 shows the change in each status. In the non-
survivors, the CFBs at each time point were significantly
higher than that in the survivors. In contrast, the total
cumulative inputs at each time point were also higher in
the non-survivors compared with that in the survivors,
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but a statistically significant difference was seen only at
48-h after CRRT start, while the total cumulative out-
puts at each time point were significantly lower in the
non-survivors than those in the survivors.
The effect of CFB on mortality risk
We next investigated the impact of 24- and 72-h CFB on
7- and 28-day mortality risk. Univariable Cox propor-
tional hazard analysis showed that increased CFB at 24-
and 72-h was significantly associated with an increase in
7-day mortality risk [increase of 1 L per 24-h CFB;
hazard ratio (HR) = 1.15, 95% confidence interval (CI) =
1.09–1.22, and an increase of 1 L per 72-h CFB; HR =
1.12, 95% CI = 1.07–1.16] and 28-day mortality risk
[increase of 1 L per 24-h CFB; HR = 1.14, 95% CI =
1.08–1.20 and increase of 1 L per 72-h CFB; HR = 1.10,
95% CI = 1.06–1.14]. Moreover, the increase of CFB at
each time point was still significantly related to the
elevation of 7-day mortality rate [increase of 1 L per
24-h CFB; HR = 1.14, 95% CI = 1.06–1.22 and increase
of 1 L per 72-h CFB; HR = 1.10, 95% CI = 1.05–1.15]
and 28-day mortality rate [increase of 1 L per 24-h
CFB; HR = 1.11, 95% CI = 1.04–1.18 and increase of 1
L per 72-h CFB; HR = 1.07, 95% CI = 1.03–1.12], even
after adjusting for confounding factors (Table 3 and
Fig. 2).
The interactive effect of cumulative input and output on
the impact of CFB on mortality
We stratified the patients into three groups based on the
tertile of 24-h and 72-h cumulative input or output. The
baseline characteristics of each group are shown in Add-
itional file 1: Table S3. The patients in the higher input
tertile were younger and showed higher baseline eGFR
levels and SOFA scores than those in the lowest tertile
at both 24-h and 72-h assessment after CRRT initiation.
However, output tertile groups showed no significant
differences in clinical characteristics, including blood
pressure, comorbidity status, and SOFA scores at either
24-h or 72-h assessment after CRRT initiation. We then
Table 1 Baseline characteristics
Overall
(n = 258)
28-day survival P
Survivor
(n = 101)
Non-survivor
(n = 157)
Demographic data
Age, years 64.7 ± 15.8 64.0 ± 17.3 65.1 ± 14.8 0.59
Male, n (%) 165 (64.0) 66 (65.3) 99 (63.1) 0.41
ICU admission body weight, kg 61.2 ± 12.2 61.7 ± 12.3 60.8 ± 12.3 0.59
ICU admission BMI, kg/m2 22.9 ± 12.2 23.2 ± 4.0 22.7 ± 3.8 0.27
Cause of AKI, n (%) 0.67
Septic 157 (60.9) 58 (57.4) 99 (63.1)
Cardiogenic 28 (10.9) 13 (12.9) 15 (9.6)
Ischemic 52 (20.2) 23 (22.8) 29 (18.5)
Postoperative 7 (2.7) 1 (1.0) 6 (3.8)
Drug induced 11 (4.3) 5 (5.0) 6 (3.8)
Others 3 (1.2) 1 (1.0) 2 (1.3)
Comorbidities, n (%)
Hypertension 125 (48.4) 58 (57.4) 67 (42.7) 0.01
Diabetes 93 (36.0) 42 (41.6) 51 (32.5) 0.09
CVDs 81 (31.4) 32 (31.7) 49 (31.2) 0.52
Malignancy 23 (9.0) 4 (4.0) 19 (12.1) 0.02
Charlson Comorbidity Index 6.5 ± 2.4 6.4 ± 2.3 6.5 ± 2.5 0.59
SOFA score 11.6 ± 3.9 9.8 ± 3.8 12.8 ± 3.5 < 0.001
APACHE II score 26.0 ± 6.7 22.9 ± 6.6 28.1 ± 6.0 < 0.001
Glasgow Coma Score 6.3 ± 4.0 8.0 ± 4.3 5.2 ± 3.4 < 0.001
Mechanical ventilation needs, n (%) 203 (79.9) 69 (69.0) 134 (87.0) < 0.001
FiO2 0.5 ± 0.2 0.4 ± 0.2 0.6 ± 0.2 0.004
Data were presented as mean ± standard deviation or number (%)
Abbreviation: ICU intensive care unit, BMI body mass index, AKI acute kidney injury, CVD cardiovascular disease, SOFA Sequential Organ Failure Assessment,
APACHE Acute Physiology and Chronic Health Evaluation, FiO2 fraction of inspired oxygen
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investigated the impact of CFB on the mortality in each
group. Increases in 24-h CFB were significantly associ-
ated with the increase in 7- and 28-day mortality risks
irrespective of the cumulative input, even after adjusting
for age, sex, BMI, MAP, CCI, history of diabetes and
hypertension, hemoglobin, eGFR, SOFA score, use of va-
sopressors, and type of fluid administration (Table 4 and
Fig. 3). Moreover, the increases in 72-h CFB were also
significantly related to the increase in 7- and 28-day
mortality risk regardless of cumulative input, except for
the T2 group for 7-day mortality. However, we did not
find significant associations between the increase in 24-
and 72-h CFB and 7- and 28-day mortality risk in the
groups stratified according to cumulative output tertile.
Instead, CFB was significantly related to an increase in
7- and 28-day mortality risk only in the T2 group of the
24-h cumulative output, and the T1 group of the 72-h
cumulative output. Taken together, we surmise that the
Table 2 Clinical and laboratory parameters at baseline
Overall
(n = 258)
28-day survival P
Survivor
(n = 101)
Non-survivor
(n = 157)
Time from ICU admission to CRRT start, day 4.4 ± 7.7 4.3 ± 7.6 4.4 ± 7.7 0.54
SBP, mmHg 114.1 ± 22.8 118.9 ± 24.0 111.0 ± 21.5 0.007
DBP, mmHg 65.8 ± 16.0 67.7 ± 15.7 64.6 ± 16.1 0.13
MAP, mmHg 81.9 ± 15.9 84.8 ± 15.6 80.1 ± 15.9 0.02
Vasopressor use, n (%) 179 (69.4) 55 (54.5) 124 (79.0) < 0.001
Dose (NE, μg/kg/min) 0.59 [0.26–1.66] 0.50 [0.15–1.13] 0.65 [0.31–1.76] 0.06
Type of fluid administration, n (%) 0.98
0.9% sodium chloride 62 (25.7) 25 (27.2) 37 (24.8)
0.45% sodium chloride 18 (7.5) 7 (7.6) 11 (7.4)
Dextrose 113 (46.9) 42 (45.7) 71 (47.7)
Plasma solution 25 (10.4) 6 (6.5) 19 (12.8)
Lactate Ringer’s solution 23 (9.5) 12 (13.0) 11 (7.4)
Replacement of 20% albumin, n (%) 156 (60.7) 56 (56.0) 100 (63.7) 0.16
Enteral nutritional fluid, n (%) 28 (10.9) 19 (19.0) 9 (5.8) 0.001
Prescriptions of CRRT
Duration of CRRT, h 5.4 ± 6.4 7.2 ± 7.8 4.3 ± 4.9 < 0.001
Target clearance (mL/kg/h) 36.7 [34.2–40.9] 36.8 [34.1–41.5] 36.6 [34.2–39.9] 0.24
Dialysate flow rate, mL/h 1033.5 ± 164.5 1031.2 ± 181.9 1034.9 ± 152.8 0.86
Replacement flow rate, mL/h 1211.1 ± 389.9 1258.9 ± 422.9 1180.1 ± 380.8 0.12
Blood flow rate, mL/min 113.6 ± 33.0 116.5 ± 33.4 11.7 ± 32.8 0.25
Anticoagulation use, n (%) 159 (61.6) (66 (65.3) 93 (59.2) 0.19
Laboratory findings
Creatinine, mg/dL 1.4 ± 0.5 1.4 ± 0.5 1.4 ± 0.4 0.95
eGFR, mL/min/1.73m2 22.0 ± 16.5 21.3 ± 17.3 22.4 ± 16.1 0.62
White blood cells, n/μL 13.1 ± 10.4 11.8 ± 6.0 14.0 ± 12.4 0.10
Hemoglobin, g/dL 9.4 ± 2.2 9.3 ± 1.9 9.5 ± 2.3 0.59
Platelets, × 103/μL 126.8 ± 87.9 141.9 ± 91.3 117.0 ± 84.5 0.03
PT-INR 2.0 ± 3.7 1.6 ± 0.6 2.3 ± 4.7 0.14
Total bilirubin, mg/dL 2.9 ± 5.2 1.7 ± 3.3 3.7 ± 6.0 0.007
Aspartate aminotransferase, IU/L 362.5 ± 66.5 481.7 ± 140.8 285.1 ± 60.3 0.15
Alanine aminotransferase, IU/L 152.7 ± 30.8 209.0 ± 71.3 115.9 ± 20.4 0.14
Lactic acid, mg/dL 58.6 ± 5.4 57.6 ± 9.5 59.2 ± 6.5 0.89
Data were presented as mean ± standard deviation, median [interquartile range] or number (%)
Abbreviation: ICU intensive care unit, CRRT continuous renal replacement therapy, SBP systolic blood pressure, DBP diastolic blood pressure, MAP mean arterial
pressure, NE norepinephrine, eGFR estimated glomerular filtration rate, PT-INR prothrombin time-international normalized ratio
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impact of CFB on mortality might be dependent on cu-
mulative output (Table 4).
Discussion
This study shows the effects of cumulative input and
output on the impact of short-term (24-h) and relatively
long-term (72-h) CFB on 7- and 28-day mortality risk
among AKI patients undergoing CRRT. We found that
both increases in short-term and longer-term CFB were
significantly associated with increases in 7- and 28-day
mortality risk, and the effect of CFB on mortality might
be dependent on cumulative output.
The main concern in AKI patients undergoing CRRT
is how to control their volume status [26, 27]. Several
studies have examined this issue, and almost all sug-
gested that fluid overload was significantly associated
with increased mortality risk as well as aggravation of
kidney function [2, 16, 28]. Although most studies have
focused on a negative fluid balance in AKI patients with
CRRT, physicians need to consider volume resuscitation,
since it is crucial to restore and maintain hemodynamic
stability in critically ill patients [29–32]. To reduce CFB,
physicians need to choose low fluid resuscitation and
high removal of resuscitation as much as possible. We
stratified the patients in this study into three groups
based on 24-h and 72-h cumulative input or output ter-
tiles to reveal the interactive effect of cumulative input
or output on the impact of CFB on mortality. We found
a big VIF between CFB and cumulative input/output, re-
spectively, and it was difficult to adjust cumulative input
and output to show the impact of CFB on mortality risk,
independently. We also found that the increase in CFB
was still significantly associated with an increase in mor-
tality risk irrespective of the stratification of cumulative
input, which suggests that removal of more fluid output
may reduce the mortality risk. In contrast, when we per-
formed Cox analysis for mortality after patients were
Fig. 1 Comparison of fluid balance (a), total intake (b), and total output (c) between 28-day survivor vs. non-survivor. Each group was compared
by two-way ANOVA, *P < 0.001, #P = 0.03. CRRT, continuous renal replacement therapy
Table 3 The association between cumulative fluid balance and
mortality
7-day mortality 28-day mortality
HR (95% CI) P HR (95% CI) P
24-h cumulative fluid balance* (per 1.0 L increase, n = 258)
Unadjusted 1.15 (1.09–1.22) < 0.001 1.14 (1.08–1.20) < 0.001
Adjusted model† 1.14 (1.06–1.22) < 0.001 1.11 (1.04–1.18) 0.002
72-h cumulative fluid balance* (per 1.0 L increase, n = 191)
Unadjusted 1.12 (1.07–1.16) < 0.001 1.10 (1.06–1.14) < 0.001
Adjusted model† 1.10 (1.05–1.15) < 0.001 1.07 (1.03–1.12) 0.001
*Per 1.0 L increase
†Adjusted for age, sex, body mass index, mean arterial pressure, Charlson
Comorbidity Index, history of diabetes and hypertension, hemoglobin, baseline
estimated glomerular filtration rate, Sequential Organ Failure Assessment
score, use of vasopressor, and type of fluid administration. Mean arterial
pressure, hemoglobin, Sequential Organ Failure Assessment score, use of
vasopressor use, and type of fluid administration at each of baseline and 72-h
after CRRT initiation were used for adjustment in 24-h and 72-h CFB
models, respectively
Abbreviation: HR hazard ratio, CI confidence interval
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stratified based on cumulative output, there was no sig-
nificant association between CFB increase and mortality
risk, which means that reduction of cumulative input
might not decrease mortality risk.
Moreover, we also investigated the characteristics of
the three patient groups stratified by their cumulative in-
put and output at 24-h and 72-h after CRRT initiation
(Additional file 1: Table S3). Especially, there were no
significant differences in MAP, CCI, and SOFA scores
among the three groups stratified by output amount,
suggesting that fluid removal might be done irrespective
of illness severity. Therefore, we do not think a higher
rate of fluid removal is simply a marker of lower illness
severity. Instead, more fluid removal could provide an
indirect benefit against the oxygen-mismatched diffusion
and distorted tissue architecture that originate from fluid
overload and tissue edema. Taken together, we suggest
that physicians need to pay closer attention to decreas-
ing CFB, especially by increasing fluid removal, to im-
prove the clinical outcomes of their AKI patients
receiving CRRT.
Adequate fluid resuscitation is essential to restore tissue
perfusion in critically ill patients with AKI [27, 33, 34],
and fluid administration contributes to improve glomeru-
lar filtration [9]. Moreover, fluid administration is aimed
to restore systemic blood pressure, a major determinant of
renal perfusion pressure and cardiac output [35–37]. In
particular, patients with severe sepsis need adequate fluid
resuscitation within 1 to 3 h of disease onset to overcome
their hemodynamically unstable state [38, 39]. Thus, clini-
cians may try to administer more fluid to restore tissue
perfusion and to improve disease course. However, fluid
overload and tissue edema physiologically result in im-
paired diffusion of oxygen and metabolites, distorted
tissue architecture, obstruction of capillary blood flow or
lymphatic drainage, and disturbed cell-cell interactions.
These processes subsequently contribute to progressive
organ dysfunction. The patients in the current study were
more likely to be overhydrated at CRRT start, and their
severity scores (SOFA and APACHE II score) were higher
than those in other studies [25, 40]. Thus, more removal
of patient output seems to be more effective for a decrease
Fig. 2 Cubic spline plots for the 7- or 28-day mortality risks according to 24-h (a, b) and 72-h (c, d) cumulative fluid balance. Black lines = hazard
ratios, dotted lines = 95% confidence intervals
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in mortality compared with lower cumulative input, and
interpretation of the current study should be made with
caution. Generally, most AKI patients who require CRRT
are critically ill and in an overhydrated condition [27, 41].
Moreover, effective circulating volume appears to be low
in these patients [8]. Thus, we surmise that it might be
more helpful to increase fluid removal than to decrease in-
put. Furthermore, Murugan et al. [42] recently showed
that higher ultrafiltration intensity (> 25mL/kg/day) was
associated with lower risk for mortality compared with
lower ultrafiltration intensity (≤ 20mL/kg/day) among
critically ill patients with fluid overload who were under-
going CRRT. The authors suggested several reasons for
the benefit of intensive removal. First, increase in cumula-
tive output may reduce the risk of subsequent edema-
related organ dysfunction [43]. Second, the increase in cu-
mulative output by intensive net ultrafiltration may lead
to better clearance of unknown molecules and contribute
to better survival independently of fluid balance [44].
There are several limitations in the current study.
First, this study was a retrospective study conducted in a
single center with a relatively small sample size. Thus,
selection bias was not completely avoidable, and these
results may not be applicable to other ethnicities.
Nevertheless, we assessed the power of our study sample
size, and it was more than 80%, showing the robustness
of our study sample size (Additional file 1: Table S4). In
addition, previous studies with AKI patients undergoing
CRRT were performed with sample sizes similar to ours
[3, 45]. Moreover, this is the first study, to the best our
knowledge, to reveal the interactive effect of fluid input
and output in managing fluid balance for CRRT-treated
AKI patients, so it can serve as precedent research for
future prospective interventional studies with more pa-
tients that are needed to verify our study results. Second,
we could not measure the effects of diet or drugs used
or insensible water loss. However, most of these patients
could not eat and nutritional support was provided via
an infused solution for 72-h from CRRT start [only 28
(10.9%) patients were supplied with enteral nutritional
fluid]. Third, physicians wanted to increase mechanical
fluid removal when their patients could endure the in-
crease in fluid removal, suggesting that patients whose
removal was increased would experience better clinical
outcomes. Several studies investigating the effect of fluid
overload on mortality in critically ill patients have been
performed, and most of these studies showed that a high
CFB was significantly associated with increased mortality
Table 4 The association between 24-h and 72-h cumulative fluid balance and mortality at different levels of total input and output
7-day mortality 28-day mortality
HR (95% CI) P HR (95% CI) P
24-h cumulative fluid balance* (per 1.0 L increase, n = 258)†
Total input (L)
T1 (≤ 2.81) 1.96 (1.32–2.91) 0.001 1.98 (1.39–2.83) < 0.001
T2 (2.82–4.36) 1.79 (1.16–2.77) 0.008 1.36 (1.01–1.83) 0.04
T3 (> 4.36) 1.15 (1.02–1.29) 0.02 1.12 (1.01–1.25) 0.04
Total output (L)
T1 (≤ 0.69) 0.91 (0.79–1.04) 0.18 0.92 (0.81–1.05) 0.22
T2 (0.70–2.13) 1.26 (1.08–1.47) 0.003 1.28 (1.12–1.47) < 0.001
T3 (> 2.13) 1.16 (0.95–1.43) 0.15 1.04 (0.86–1.26) 0.70
72-h cumulative fluid balance* (per 1.0 L increase, n = 191)†
Total input (L)
T1 (≤ 7.48) 1.34 (1.01–1.77) 0.04 1.29 (1.04–1.59) 0.02
T2 (7.49–11.1) 1.56 (0.96–2.52) 0.07 1.50 (1.15–1.96) 0.003
T3 (> 11.1) 1.14 (1.05–1.23) 0.001 1.08 (1.01–1.15) 0.02
Total output (L)
T1 (≤ 4.27) 1.08 (1.01–1.15) 0.03 1.08 (1.02–1.15) 0.01
T2 (4.28–7.14) 1.22 (0.99–1.49) 0.06 1.16 (0.98–1.38) 0.09
T3 (> 7.14) 1.18 (0.98–1.41) 0.08 1.04 (0.94–1.16) 0.44
*per 1.0 L increase
†Adjusted for age, sex, body mass index, mean arterial pressure, Charlson Comorbidity Index, history of diabetes and hypertension, hemoglobin, baseline
estimated glomerular filtration rate, Sequential Organ Failure Assessment score, use of vasopressor, and type of fluid administration. Mean arterial pressure,
hemoglobin, Sequential Organ Failure Assessment score, use of vasopressor use, and type of fluid administration at each of baseline and 72-h after CRRT initiation
were used for adjustment in 24-h and 72 h-CFB models, respectively
Abbreviation: HR hazard ratio, CI confidence interval, T tertiles
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risk. However, it seems to be a case of the chicken and
the egg. It can be difficult to increase fluid removal when
patients are hemodynamically unstable, which suggests
that greater illness severity, rather than increased CFB
might be leading to worse clinical outcomes. In this
study, however, we tried to adjust the severity indices,
such as MAP, CCI, and SOFA score, to exclude the ef-
fect of those factors on mortality and we found that high
CFB was still significantly related to an increase in 7-
and 28-day mortality independently of the severity indi-
ces. Taken together, we surmise that fluid removal itself
might provide an indirect benefit for clinical outcomes
by improving tissue oxygenation, not just that a higher
rate of fluid removal is a marker of lower severity of ill-
ness. Fourth, we arbitrarily stratified these patients into
three groups based on cumulative input and/or output
to examine the interaction of input and/or output on
CFB impact on mortality. However, we investigated the
interaction between CFB and cumulative input and out-
put and found that VIF was too large to be adjusted with
CFB. Thus, we decided to analyze the effect of cumula-
tive input and output on the impact of CFB on mortality
after stratifying the patients. Finally, we used eGFR as a
marker of the patients’ renal function status, even
though it is not a valid reflection of renal function in an
acute setting. In this study, we could not have evaluated
baseline kidney function with gold standard methods for
GFR measurement such as inulin clearance, so we only
used calculated eGFR values with MDRD equation. Fur-
ther study is needed to accurately compare baseline
kidney function measured by gold standard methods.
Despite these limitations, this study reports robust
Fig. 3 Comparison of adjusted hazard ratios for 7-day or 28-day mortality according to 24-h (a, b) or 72-h (c, d) cumulative fluid balance stratified
with tertiles of total input and output. T1–3 represents tertile groups of total input and output. The exact values of T1–3 are presented in Table 4.
Models were adjusted for age, sex, body mass index, mean arterial pressure, Charlson comorbidity index, history of diabetes and hypertension,
hemoglobin, baseline estimated glomerular filtration rate, Sequential Organ Failure Assessment score, use of vasopressor, and type of fluid
administration. Mean arterial pressure, hemoglobin, Sequential Organ Failure Assessment score, use of vasopressor use, and type of fluid
administration at each of baseline and 72-h after CRRT initiation were used for adjustment in 24-h and 72 h-cumulative fluid balance models,
respectively. *P < 0.05, **P < 0.01, ***P < 0.001. CRRT, continuous renal replacement therapy
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clinical findings for the effect of an increase in short-
term and longer-term CFB on mortality risk and the
dependence of CFB on cumulative output.
Conclusions
In conclusion, an increase in CFB was significantly asso-
ciated with an increase in mortality risk in AKI patients
undergoing CRRT, irrespective of cumulative period.
Moreover, the impact of CFB on mortality might be
dependent on cumulative output. Although a prospect-
ive interventional study with a larger number of patients
will be needed, this study revealed that physicians need
to decrease the CFB of CRRT patients as much as pos-
sible and to consider increasing the amount of fluid
removal.
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